Researchers develop 3D bioprinting technology for eliminating cancer cells

FHS
July 12, 2023
3:19 am

A three-dimensional (3D) bioprinting technology capable of eliminating cancer cells using the function of immune cells has been developed for the first time in the world.

BioNTech opens the hood on its AI ambitions, and they’re not just for mRNA

Sign up for free to read a limited number of articles each month. Pick what newsletters get delivered to your inbox each week. Biopharma ENDPOINTS

October 3, 2024

Does taxing sugary drinks lead to health benefits?

Researchers identify a significant association between sugar-sweetened beverage tax and BMI changes among adults living in Berkeley, California.

January 30, 2025

Johnson & Johnson agrees to acquire Ambrx Biopharma for $2bn

Share this article The acquisition of Ambrx by Johnson & Johnson is anticipated to conclude in the first half of 2024. Credit: josefkubes / Shutterstock.com.

January 9, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.